Status:

COMPLETED

Immune Response in Hypersensitivity Pneumonitis

Lead Sponsor:

Nabeel Hamzeh

Collaborating Sponsors:

National Jewish Health

Conditions:

Hypersensitivity Pneumonitis

Eligibility:

All Genders

18-80 years

Brief Summary

Hypersensitivity pneumonitis (HP) is an inflammatory lung disease that is caused by exposure of susceptible individuals to organic materials in the environment. It is also known by various names depen...

Detailed Description

Hypersensitivity pneumonitis (HP) is a granulomatous lung disorder triggered by exposure to one of a multitude of organic antigens. Incidence rates of HP vary by geography, season and population studi...

Eligibility Criteria

Inclusion

  • Inclusion:
  • Adult between the ages of 18 and 80 years old.
  • Non-smoker or previous smoker quit \>6months ago.
  • Radiological findings compatible with sub-acute or chronic HP4.
  • Histopathological findings compatible with sub-acute or chronic HP4.
  • Able to understand the consent process and procedures involved in the study.
  • Exclusion:
  • Unable to understand the consent process or procedures involved in the study.
  • End-stage lung disease defined as predominantly honeycombing on chest CT and/or FVC\<60% and/or DLCO \<30%.
  • Requiring high oxygen needs \>4L.
  • Pregnancy.
  • Treated with a biological agent within the past 6 months.
  • Suspicion of current infection or within the past 3 months.
  • Bleeding disorder or on anti-coagulants other than aspirin.
  • Any co-morbid condition that increases risk of bronchoscopy including but not limited to cardiac disease, uncontrolled hypertension, uncontrolled diabetes and/or morbid obesity.

Exclusion

    Key Trial Info

    Start Date :

    November 29 2018

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 30 2022

    Estimated Enrollment :

    21 Patients enrolled

    Trial Details

    Trial ID

    NCT03873649

    Start Date

    November 29 2018

    End Date

    March 30 2022

    Last Update

    May 18 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Iowa

    Iowa City, Iowa, United States, 52242

    Immune Response in Hypersensitivity Pneumonitis | DecenTrialz